Stock JNJ JOHNSON & JOHNSON
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Johnson & Johnson

Equities

JNJ

US4781601046

Pharmaceuticals

Real-time Estimate Cboe BZX
Other stock markets
 09:59:20 2025-01-21 EST 		5-day change 1st Jan Change
148.58 USD +1.05% Intraday chart for Johnson & Johnson +2.42% +2.51%
09:44am J&J: FDA approves Spravato spray for depression CF
09:16am J&J: EU approves Lazcluze for lung cancer treatment CF

Chart calendar Johnson & Johnson

11b011f08d6edd1fe.sJRKDNth15oJbQz_30uLp-lWKoA390YP6dYap1AQ3Tc.gaI9YokogPNENWK9lB7x958uesVWgy5Wm6B042lksFP54Cx6qxC67jsUYw~090a4526f70aa8871af053e056833d4a

Upcoming events on Johnson & Johnson

2025-01-22 06:45 Q4 2024 Earnings Release
2025-01-22 08:30 Q4 2024 Earnings Call
2025-02-17 Détachement de
2025-04-14 Q1 2025 Earnings Release Pre-market
2025-04-15 08:30 Q1 2025 Earnings Call
2025-07-21 Q2 2025 Earnings Release (Projected)
2025-10-20 Q3 2025 Earnings Release (Projected)
2026-01-26 Q4 2025 Earnings Release (Projected)
2026-04-20 Q1 2026 Earnings Release (Projected)

Past events on Johnson & Johnson

2025-01-13 12:00 JP Morgan Healthcare Conference
2024-12-08 American Society of Hematology Meeting - Abstract #1032
2024-11-25 Détachement de
2024-11-18 14:00 American College of Rheumatology Meeting - scRNAseq SjD Predictors
2024-11-18 10:55 Stifel Healthcare Conference
2024-11-18 10:30 American College of Rheumatology Meeting - Poster No:2047
2024-11-18 10:30 American College of Rheumatology Meeting - Poster No:2357
2024-11-18 10:30 American College of Rheumatology Meeting - Poster No:2353
2024-11-18 10:30 American College of Rheumatology Meeting - Poster No:1904
2024-11-18 10:30 American College of Rheumatology Meeting - Poster No:2316
2024-11-18 10:30 American College of Rheumatology Meeting - Poster No:2342
2024-11-18 10:30 American College of Rheumatology Meeting - Poster No:1912
2024-11-18 10:30 American College of Rheumatology Meeting - Poster No:2001
2024-11-18 10:30 American College of Rheumatology Meeting - Poster No:2416
2024-11-18 10:30 American College of Rheumatology Meeting - Poster No:1976
2024-11-18 10:30 American College of Rheumatology Meeting - Poster No:1988
2024-11-18 10:30 American College of Rheumatology Meeting - Poster No:2294
2024-11-18 09:00 American College of Rheumatology Meeting - Poster No:2527
2024-11-17 15:00 American College of Rheumatology Meeting - BRASS 3 RA Remission
2024-11-17 10:30 American College of Rheumatology Meeting - Poster No:1496

Past dividends on Johnson & Johnson

2024-11-25 Quarterly 1.24 USD
2024-08-26 Quarterly 1.24 USD
2024-05-19 Quarterly 1.24 USD
2024-02-15 Quarterly 1.19 USD
2023-11-19 Quarterly 1.19 USD
2023-08-24 Quarterly 1.19 USD
2023-05-21 Quarterly 1.19 USD
2023-02-16 Quarterly 1.13 USD
2022-11-20 Quarterly 1.13 USD
2022-08-21 Quarterly 1.13 USD
2022-05-22 Quarterly 1.13 USD
2022-02-17 Quarterly 1.06 USD
2021-11-21 Quarterly 1.06 USD
2021-08-22 Quarterly 1.06 USD
2021-05-23 Quarterly 1.06 USD
2021-02-21 Quarterly 1.01 USD
2020-11-22 Quarterly 1.01 USD
2020-08-23 Quarterly 1.01 USD
2020-05-21 Quarterly 1.01 USD
2020-02-23 Quarterly 0.95 USD

Annual results

Fiscal PeriodDecember 2021 2022 2023 2024 2025 2026
Net sales
Million USD		Released
Forecast
Spread 		93 775
94 304
-0.56%		94 943
95 017
-0.08%		85 159
84 764
0.47%
88 775


91 058


94 530

EBITDA
Million USD		Released
Forecast
Spread 		36 634
33 066
10.79%		32 630
32 564
0.2%		30 414
31 998
-4.95%
30 426


32 776


34 992

EBIT
Million USD		Released
Forecast
Spread 		29 244
30 088
-2.8%		29 965
29 608
1.21%		27 460
27 881
-1.51%
27 009


29 269


31 004

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		22 776
24 759
-8.01%		21 725
25 756
-15.65%		15 062
20 454
-26.36%
20 759


22 324


23 799

Net income
Million USD		Released
Forecast
Spread 		20 878
22 542
-7.38%		17 941
20 668
-13.19%		35 153
19 696
78.48%
17 495


20 769


22 172

EPS
USD		Released
Forecast
Spread 		7,81
8,42
-7.29%		6,73
7,95
-15.29%		13,7
8,44
62.56%
6,93


8,67


9,38

Announcement Date25/01/2224/01/2323/01/24-

Quarterly results

Fiscal PeriodSeptember 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3
Net sales
Million USD		Released
Forecast
Spread 		24 746
23 599
4.86%		25 530
24 668
3.49%		21 351
21 049
1.43%		21 395
21 017
1.8%		21 383
21 386
-0.01%		22 447
22 337
0.49%		22 471
22 171
1.35%
22 448


21 943


22 776


22 992


23 135


23 162


23 905


24 271

EBITDA
Million USD		Released
Forecast
Spread 		8 880
8 484
4.66%		8 912
8 671
2.78%		8 071
7 683
5.04%		6 333
6 788
-6.7%		7 973
7 747
2.92%		8 388
8 129
3.18%		7 164
7 063
1.43%
6 262


8 473


8 387


8 266


7 447


8 782


9 000


7 895

EBIT
Million USD		Released
Forecast
Spread 		8 204
7 411
10.7%		8 189
7 753
5.62%		7 374
6 967
5.83%		5 638
6 015
-6.27%		7 236
7 203
0.46%		7 712
7 433
3.76%		6 489
6 085
6.63%
5 505


7 337


7 525


7 441


6 613


7 928


8 145


7 038

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-737
6 708
-110.99%		6 762
7 242
-6.63%		5 217
7 202
-27.56%		4 826
5 043
-4.3%		6 440
6 329
1.75%		5 748
6 910
-16.82%		3 338
4 923
-32.2%
4 591






















Net income
Million USD		Released
Forecast
Spread 		-68,0
5 573
-101.22%		5 144
5 866
-12.3%		26 028


4 049
3 880
4.34%		5 354
5 293
1.15%		4 686
5 093
-8%		2 694
4 083
-34.02%
4 304


6 898


6 913


5 940


5 636


6 848


7 033


6 128

EPS
USD		Released
Forecast
Spread 		-0,03
2,10
-101.43%		1,96
1,89
3.45%		10,2
2,17
370.51%		1,67
1,68
-0.81%		2,20
2,21
-0.57%		1,93
2,09
-7.72%		1,11
1,69
-34.13%
1,79


2,44


2,56


2,42


2,26


2,87


2,95


2,57

Announcement Date18/04/2320/07/2317/10/2323/01/2416/04/2417/07/2415/10/24--------

Upcoming sector events for Johnson & Johnson

2025-01-21 AARTI DRUGS LIMITED: Q3 2025 Earnings Release (Projected)
2025-01-21 ALEMBIC PHARMACEUTICALS LIMITED: Q3 2025 Earnings Release (Projected)
2025-01-22 06:45 JOHNSON & JOHNSON: Q4 2024 Earnings Release
2025-01-22 MANKIND PHARMA LIMITED: Q3 2025 Earnings Release
2025-01-22 ALIVUS LIFE SCIENCES LIMITED: Q3 2025 Earnings Release
2025-01-22 DR. REDDY'S LABORATORIES LIMITED: Q3 2025 Earnings Release
2025-01-23 SUPRIYA LIFESCIENCE LIMITED: Q3 2025 Earnings Release
2025-01-23 LAURUS LABS LIMITED: Q3 2025 Earnings Release
2025-01-23 TORRENT PHARMACEUTICALS LIMITED: Q3 2025 Earnings Release
2025-01-23 GRANULES INDIA LIMITED: Q3 2025 Earnings Release
More events

Past sector events for Johnson & Johnson

Today AARTI PHARMALABS LIMITED: Q3 2025 Earnings Release (Projected)
2025-01-10 07:00 TILRAY BRANDS, INC.: Q2 2025 Earnings Release
2025-01-10 04:09 LOTUS PHARMACEUTICAL CO., LTD.: December 2024 Sales and Revenue Release
2025-01-09 18:50 BORA PHARMACEUTICALS CO., LTD.: December 2024 Sales and Revenue Release
2025-01-09 05:25 SCINOPHARM TAIWAN, LTD.: December 2024 Sales and Revenue Release
2025-01-08 HISAMITSU PHARMACEUTICAL CO., INC.: Q3 2024 Earnings Release
2025-01-08 03:17 CALIWAY BIOPHARMACEUTICALS CO., LTD.: December 2024 Sales and Revenue Release
2024-12-10 11:45 MEDINCELL S.A.: Q2 2025 Earnings Release
2024-12-10 04:02 LOTUS PHARMACEUTICAL CO., LTD.: November 2024 Sales and Revenue Release
2024-12-10 01:29 CENTER LABORATORIES, INC.: November 2024 Sales and Revenue Release

Quarterly revenue - Rate of surprise

quality-estimates-chart JOHNSON-JOHNSON

Net sales - Rate of surprise

quality-estimates-chart JOHNSON-JOHNSON

Annual profits - Rate of surprise

quality-estimates-chart JOHNSON-JOHNSON
  1. Stock Market
  2. Equities
  3. JNJ Stock
  4. Calendar Johnson & Johnson
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition